Menopause, Heart and Metabolic Health: Blood Pressure, Cholesterol, Glucose and Visceral Fat

Menopause, Heart and Metabolic Health: Blood Pressure, Cholesterol, Glucose and Visceral Fat
Longevity Science · Women’s Longevity

Menopause, heart and metabolic health:
what to measure and what to change.

The menopause transition can coincide with changes in body composition, blood pressure, lipids and glucose regulation. It does not make cardiovascular disease or diabetes inevitable. The most useful strategy is to measure modifiable risk, protect muscle and fitness, address symptoms and use licensed treatment where appropriate.

39 RCTsExercise trials in a metabolic-risk meta-analysis
2,132Postmenopausal participants across those trials
61 RCTsAerobic-exercise trials in a 2025 cardiovascular review
40–74Usual NHS Health Check age range in England
MeasureBlood pressure, lipids, glucose and waist
MoveUse aerobic and resistance training together
TreatUse medicines and menopause care when indicated
ReviewTrack trends rather than waiting for symptoms
Direct Answer

Menopause is a prevention checkpoint,
not a cardiovascular diagnosis

Cardiovascular risk rises with age, and the menopause transition can contribute additional changes in fat distribution, lipids, blood pressure and insulin sensitivity. Those changes vary between women and remain strongly influenced by smoking, activity, sleep, diet, medicines, pregnancy history, family history and existing health conditions.

The practical response is not to blame every result on hormones. It is to identify the risk factors that can be measured and changed before they produce symptoms.

Five Numbers Worth Knowing
  • Blood pressure: hypertension usually causes no symptoms but increases heart, stroke and kidney risk.
  • Atherogenic cholesterol: LDL, non-HDL cholesterol or ApoB can help describe cholesterol carried in potentially harmful particles.
  • Glucose status: HbA1c or fasting glucose may be appropriate according to risk and clinical context.
  • Waist circumference: central fat distribution can change even when scale weight is stable.
  • Fitness and strength: the ability to walk briskly, climb stairs and move load reflects functional reserve.

Menopause can change the risk landscape, but prevention still depends on ordinary measurable factors rather than one hormone panel or one supplement.

Know the baseline, then improve the trend
What Changes Through Menopause

Ovarian ageing and chronological ageing
overlap but are not identical

Longitudinal menopause research has documented changes in body composition, lipids and vascular health around the transition. Earlier menopause is also associated with greater later cardiovascular risk, although this does not mean menopause alone caused every future event.

A scientific statement based heavily on longitudinal studies, including SWAN, concluded that the transition offers an important window for earlier cardiovascular prevention.

Scientific Statement on Menopause and Cardiovascular Risk

The Transition Is an Opportunity for Earlier Prevention

Longitudinal studies have identified adverse changes in body composition, lipids, lipoproteins and vascular measures across the transition. The statement emphasised risk-factor recognition rather than treating menopause as a single causal mechanism. PMID 33251828

Earlier menopause matters: menopause before the usual age range, particularly premature ovarian insufficiency, deserves individual cardiovascular and bone-health planning with a qualified clinician.

Blood Pressure

High blood pressure is usually silent,
so symptoms are a poor screening strategy

Blood pressure often rises with age and may be influenced by weight, salt intake, activity, alcohol, smoking, sleep apnoea, medicines, kidney function and genetics. Long-term stress can contribute, but it should not become the only explanation.

The NHS generally defines high blood pressure as 140/90 mmHg or higher when measured by a healthcare professional, or 135/85 mmHg or higher when measured at home. Diagnosis normally requires repeated or ambulatory readings rather than one isolated measurement.

A Better Home Check
  • Use a validated upper-arm monitor: wrist devices are more sensitive to positioning.
  • Sit quietly first: recent exercise, conversation, caffeine and rushing can alter the reading.
  • Keep the cuff at heart level: incorrect position changes the result.
  • Record several readings: a pattern is more useful than the highest number seen once.

Read current NHS guidance on high blood pressure.

Read the NHS guide to blood-pressure testing.

Cholesterol and ApoB

Cholesterol risk is about particles and context,
not whether one value is labelled good or bad

LDL and other ApoB-containing particles can enter the artery wall and contribute to atherosclerosis. HDL cholesterol is associated with cardiovascular risk, but a high HDL value does not cancel out high LDL, non-HDL cholesterol, ApoB, smoking or high blood pressure.

The NHS states that high cholesterol is more likely after menopause and usually causes no symptoms. Testing is the only way to know the level.

A Useful Lipid Discussion Can Include
  • Total and HDL cholesterol: commonly used within UK risk assessment.
  • Non-HDL or LDL cholesterol: better reflects cholesterol carried in atherogenic particles.
  • Triglycerides: influenced by alcohol, glucose regulation, weight, diet and fasting status.
  • ApoB or Lp(a): may be useful in selected people according to family and clinical risk.

Read current NHS guidance on high cholesterol.

Read the NHS guide to cholesterol testing.

Glucose and Insulin Resistance

Muscle, visceral fat and sleep all influence
how efficiently glucose is managed

Type 2 diabetes develops when insulin does not work effectively enough or the pancreas cannot produce enough to meet demand. Risk is shaped by age, family history, ethnicity, body composition, previous gestational diabetes, activity, sleep and medicines.

The menopause transition may contribute through changes in fat distribution and lean mass, but ordinary prevention remains powerful: regular movement, muscle-preserving training, a balanced diet, appropriate weight management and clinical treatment where needed.

Testing May Be Relevant When
  • There is central weight gain or a strong family history.
  • Gestational diabetes occurred in a previous pregnancy.
  • Blood pressure, triglycerides or other metabolic risks are elevated.
  • Symptoms include persistent thirst, frequent urination, unexplained weight loss or recurrent infections.

Read the NHS explanation of type 2 diabetes and insulin resistance.

Visceral Fat and Waist

Where fat is stored can matter
as much as total body weight

Visceral fat sits around internal organs and is more strongly associated with metabolic risk than subcutaneous fat beneath the skin. Menopause can shift fat distribution towards the abdomen even without a dramatic rise in total weight.

Waist circumference is an imperfect but practical marker. It should be interpreted with height, ethnicity, body composition, pregnancy history and overall clinical risk rather than used as a diagnosis by itself.

Human Adipose-Tissue Study · Women Aged 45 to 60

Postmenopausal Changes Were Associated with Greater Visceral Fat

The study identified changes in adipose-tissue size, inflammation and fibrosis associated with increased visceral fat and reduced insulin sensitivity. It was cross-sectional and does not prove that menopause alone caused the differences. PMID 34285301

Exercise Changes Several Risks at Once

Aerobic and resistance training
provide complementary benefits

Aerobic exercise is particularly useful for cardiorespiratory fitness, blood pressure and lipid outcomes. Resistance training protects muscle, improves strength and provides a glucose-disposal stimulus. Combined programmes address both systems.

Systematic Review and Meta-Analysis · 39 RCTs · 2,132 Women

Exercise Improved Every Analysed Metabolic-Syndrome Risk Factor

Exercise reduced waist circumference, triglycerides, fasting glucose and blood pressure while improving HDL cholesterol across postmenopausal participants. Effects varied by health status, programme and study quality. PMID 36736057

Systematic Review and Meta-Analysis · 61 RCTs · 4,100 Women

Aerobic Exercise Improved Blood Pressure and Lipid Measures

Aerobic exercise reduced systolic and diastolic blood pressure, LDL cholesterol and triglycerides while increasing HDL cholesterol. Effects on total cholesterol were not significant. PMID 40742785

A Complete Weekly Pattern
  • Two strength sessions: progressively train the major muscle groups.
  • Regular aerobic work: brisk walking, cycling, rowing, swimming or another suitable activity.
  • Movement throughout the day: break up long sedentary periods.
  • Progress gradually: consistency matters more than using the hardest possible session.
Dietary Pattern

The goal is a sustainable pattern,
not a menopause-specific detox

A cardiometabolic eating pattern emphasises vegetables, fruit, pulses, wholegrains, nuts, seeds, fish, lean protein and unsaturated fats while limiting excess salt, free sugars and highly processed foods.

Protein helps preserve muscle, while soluble fibre and food quality support satiety and lipid management. Alcohol can worsen sleep, hot flushes, blood pressure and triglycerides in some women.

01

Protein

Include a meaningful source at meals to support muscle and satiety.

02

Fibre

Use oats, beans, pulses, fruit, vegetables and wholegrains regularly.

03

Unsaturated Fats

Use olive oil, nuts, seeds and oily fish within overall energy needs.

04

Salt and Alcohol

Both can be relevant to blood pressure, sleep and metabolic markers.

View the official UK Eatwell Guide.

Sleep and Vasomotor Symptoms

Night sweats can affect risk indirectly
through sleep, appetite and recovery

Persistent sleep disruption can reduce training quality, increase hunger and make blood-pressure and glucose management harder. Treating vasomotor symptoms may therefore support the behaviours that protect long-term health.

This does not mean every sleep problem is menopausal. Loud snoring, breathing pauses, severe daytime sleepiness and persistent insomnia deserve appropriate assessment.

HRT and Cardiovascular Risk

HRT treats menopause symptoms,
but it is not prescribed as a heart-disease preventive

NICE advises against offering combined or oestrogen-only HRT for the primary or secondary prevention of cardiovascular disease. HRT decisions should focus on symptoms, bone protection, age, timing, medical history, route, formulation and personal priorities.

The cardiovascular and clotting profile differs between oral and transdermal formulations and between individuals. A history of thrombosis, stroke, cardiovascular disease, migraine or other risk factors may change the preferred approach.

NICE Menopause Guideline · Updated April 2026

Do Not Offer HRT Specifically to Prevent Cardiovascular Disease

NICE directs cardiovascular prevention towards risk assessment, lifestyle and lipid-management guidance rather than prescribing HRT for prevention alone. Read the recommendations.

Read the NHS guide to HRT benefits, risks and formulations.

The NHS Health Check

Screening is useful because several major risks
cause no early symptoms

In England, adults aged 40 to 74 without certain pre-existing cardiovascular conditions are generally invited for a free NHS Health Check every five years. It assesses heart and blood-vessel health and can identify increased risk of heart disease, stroke, kidney disease and diabetes.

People already diagnosed with high blood pressure, diabetes, cardiovascular disease or related conditions should receive condition-specific monitoring rather than relying on the general check.

Use the Appointment to Review
  • Blood pressure and cholesterol.
  • Diabetes risk and relevant glucose testing.
  • Smoking, alcohol, activity and family history.
  • Pregnancy history, including gestational diabetes or hypertensive disorders.

Read the current NHS Health Check eligibility guidance.

When Symptoms Need Urgent Assessment

Do not label new cardiovascular symptoms
as stress, anxiety or menopause

Seek Timely Medical Help For
  • Chest pressure, pain or heaviness, especially with exertion, sweating, nausea or breathlessness.
  • Sudden facial weakness, arm weakness or speech difficulty.
  • New fainting, sustained palpitations or marked breathlessness.
  • One-sided leg swelling or sudden unexplained breathlessness, particularly during HRT or after immobility.
  • Persistent thirst, frequent urination or unexplained weight loss.
A Practical Cardiometabolic Plan

Work through the modifiable risks
in a clear and repeatable order

The Measure, Move, Fuel, Treat Framework
  • Measure: establish blood pressure, lipids, glucose risk, waist and fitness.
  • Move: combine progressive resistance training, aerobic work and daily movement.
  • Fuel: prioritise protein, fibre, plants and unsaturated fats within suitable energy intake.
  • Treat: use HRT for appropriate menopause indications and cardiovascular medicines when clinically needed.
  • Review: repeat meaningful measures after enough time for the plan to work.
Where Supplements Fit

Supplements may support nutrition,
but they do not replace risk assessment or treatment

No food supplement should be presented as treating hypertension, diabetes, high cholesterol or cardiovascular disease. Metabolic ingredients may also interact with glucose-lowering, anticoagulant and other medicines.

The Metabolic Reset Stack combines metabolic and cellular-energy support for suitable adults using it alongside balanced nutrition, resistance training and regular aerobic activity. It is not a substitute for prescribed treatment, glucose monitoring or cardiovascular assessment.

Explore Related NovusDNA Guides

Connect heart and metabolic health
to the systems that protect healthspan

Metabolic and Cellular Support

Support daily metabolic processes
inside a complete prevention plan

The Metabolic Reset Stack brings together metabolic and creatine-based cellular-energy support. It is designed to complement resistance training, aerobic activity and balanced nutrition, not to treat diabetes, hypertension or high cholesterol.

£47.99 Metabolic Reset Stack
Metabolic Reset StackMetabolic and creatine-based cellular-energy support£47.99
Metabolic+Berberine HCl and milk thistle£29.99
Micronised CreatineCreatine monohydrate for training and cellular-energy support£29.99
Essential+ (60 Capsules)Vitamin D3, K2 and magnesium£15.99

Metabolic+ contains berberine HCl and may be unsuitable with diabetes medicines, anticoagulants, pregnancy, breastfeeding or some medical conditions. Essential+ contains vitamin K2. Check suitability with a pharmacist or clinician where regular medicines are used.

References

1Menopause transition and cardiovascular-risk prevention. PMID 33251828
2Menopause transition and cardiovascular risk review. PMID 38555760
3Menopause, visceral fat and adipose-tissue changes. PMID 34285301
4Exercise and metabolic-syndrome risk factors. PMID 36736057
5Aerobic exercise and cardiovascular outcomes after menopause. PMID 40742785
6Exercise and lipid profiles during and after menopause. PMID 40053039
7NICE menopause recommendations, updated April 2026. NICE NG23
8NHS high-blood-pressure guidance. NHS
9NHS high-cholesterol guidance. NHS
10NHS type 2 diabetes guidance. NHS
11NHS Health Check. NHS
12UK Eatwell Guide. GOV.UK

This article is for general education and does not diagnose, treat or prevent disease. Chest pain, stroke symptoms, fainting, severe breathlessness, sustained palpitations or symptoms of markedly abnormal glucose require timely medical assessment.